ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,070Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 107

$413K Total Retail Price of All Prescriptions

Rank: 41 out of 107

490 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 490 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

9% of this provider’s 490 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 6,802 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
WARFARIN SODIUM 461 447 1 8
LEVOTHYROXINE SODIUM 405 330 2 1
SIMVASTATIN 285 201 3 2
FUROSEMIDE 277 240 4 3
OMEPRAZOLE 249 201 5 6
METOPROLOL TARTRATE 241 203 6 7
SERTRALINE HCL 187 162 7 12
LISINOPRIL 178 142 8 4
HYDROCODONE-ACETAMINOPHEN 149 101 S3 9 20
POTASSIUM CHLORIDE 149 144 9 18
AMLODIPINE BESYLATE 146 125 11 5
DONEPEZIL HCL 136 136 12 10
MIRTAZAPINE 124 122 13 16
GABAPENTIN 119 107 14 11
PANTOPRAZOLE SODIUM 111 105 15 28
CITALOPRAM HBR 104 98 16 9
NAMENDA 94 94 17 19
RISPERIDONE 92 92 18 26
ATORVASTATIN CALCIUM 89 84 19 17
QUETIAPINE FUMARATE 88 78 20 31
DIGOXIN 78 78 21 37
ATENOLOL 66 61 22 21
TAMSULOSIN HCL 66 52 22 27
METOPROLOL SUCCINATE 63 63 24 15
PREDNISONE 63 58 24 39
ZOLPIDEM TARTRATE 61 51 26 38
KLOR-CON M10 60 44 27 97
JANUVIA 60 45 27 71
EXELON 59 59 29 111
KLOR-CON M20 58 45 30 45
METFORMIN HCL 57 41 31 13
HYDROCHLOROTHIAZIDE 57 41 31 14
ESCITALOPRAM OXALATE 57 40 31 40
CYMBALTA 56 48 34 52
CLOPIDOGREL 55 49 35 29
FLOVENT HFA 53 30 36 283
AZITHROMYCIN 50 41 37 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.